KatelynMaeAtkinsMD

Radiation Oncology • Los Angeles, CA

Physician

Join to view full profile

Dr. Atkins is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Atkins' full profile

Already have an account?

Office
8700 Beverly Blvd
Los Angeles, CA 90048
Phone+1 310-423-2178

Education & Training

Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2015 - 2019
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Radiation Oncology, 2014 - 2018
Oregon Health and Science University School of MedicineClass of 2014

Certifications & Licensure

OR State Medical License 2014 - Present
CA State Medical License 2019 - 2025
MA State Medical License 2015 - 2023
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

Inductee Alpha Omega Alpha Honor Medical Society

Publications & Presentations

PubMed

ctDNA-guided adjuvant immunotherapy in colorectal cancer.
Nicholas Burley, Yurhee Lee, Louisa Liu, Alexandra Gangi, Yosef Nasseri
Immunotherapy. 2024-11-17
Irradiated Bone Marrow Volume is Associated With Hematologic Toxicity in Patients With Multiple Myeloma.
Samuel C Zhang, Sungjin Kim, Jennifer Steers, Bradley Stiehl, Katrina D Silos
International Journal of Radiation Oncology, Biology, Physics. 2024-10-28
Optimizing Cardiovascular Risk Prediction From CT Imaging at the Radiation Oncology Point of Care.
Katelyn M Atkins, Andriana P Nikolova
JACC. Cardiooncology. 2024-08-01

Journal Articles

Association of Left Anterior Descending Coronary Artery Radiation Dose with Major Adverse Cardiac Events and Mortality in Patients with Non–Small Cell Lung Cancer
Katelyn M Atkins, David E Kozono, Elizabeth H Baldini, Raymond H Mak, JAMA Oncology

Lectures

A phase I study of nanoliposomal irinotecan and 5-fluorouracil/folinic acid in combination with interleukin-1-alpha antagonist for advanced pancreatic cancer patients ...
ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/24/2020

Press Mentions

Making Radiation Therapy Safer for the HeartSeptember 13th, 2024
Radiotherapy Dose to Cardiac Substructures Linked to ArrhythmiasAugust 28th, 2024
Prostate Cancer Treatment May Raise Heart RisksJuly 27th, 2022
Join now to see all